BDMD vs NSYS

The Advanced Deterministic Scorecard reveals a critically weak financial profile with a Piotroski F-Score of just 3/9, indicating poor financial health. Despite a seemingly reasonable Price/Book of 0.77 and a strong Gross Margin of 86.94%, the company is deeply unprofitable with negative operating and net margins, collapsing revenue, and no analyst coverage. The complete absence of Altman Z-Score and intrinsic value calculations, combined with a 5-year return of -89.3%, signals severe distress. Technical indicators and insider sentiment are also weak, reinforcing a high-risk outlook.

NSYS exhibits a severe disconnect between its fundamental health and recent price action. The Piotroski F-Score of 2/9 indicates weak operational efficiency and financial deterioration, yet the stock is trading near its 52-week high with significant 1-year gains (+82.1%). While valuation metrics like Price/Sales (0.34) and Price/Book (1.18) suggest the company is undervalued relative to its assets and revenue, the thin profit margins and sluggish growth (5.9%) provide little fundamental support for the current price surge.